The novel protein MANI modulates neurogenesis and neurite-cone growth

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 8, 2011, Pages 1713-1725

  Mishra, Manisha ^a   Akatsu, Hiroyasu ^b   Heese, Klaus ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Fukushimura Hospital   (Japan)

Author keywords

Myelin; Neurites; Nogo; Parkinson's disease; Regeneration

Indexed keywords

CDC27 PROTEIN, RAT; CELL CYCLE PROTEIN; MANI PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN; C57BL MOUSE; CELL STRAIN; FEMALE; GENE EXPRESSION; GENETICS; GROWTH CONE; HELA CELL; HUMAN; MALE; METABOLISM; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURITE; PARKINSON DISEASE; PATHOLOGY; PROTEIN BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GROWTH CONES; HELA CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEURITES; NEUROGENESIS; PARKINSON DISEASE; PC12 CELLS; PROTEIN BINDING; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

MAMMALIA;

EID: 79960325643     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01134.x     Document Type: Article

References (48)

1. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2003; 43: 545-84.
2. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004; 430: 631-9.
3. Heese K, Akatsu H. Alzheimer's disease-an interactive perspective. Curr Alzheimer Res. 2006; 3: 109-21.
4. Yokota T, Mishra M, Akatsu H, et al. Brain site-specific gene expression analysis in Alzheimer's disease patients. Eur J Clin Invest. 2006; 36: 820-30.
5. Nagai Y, Ogasawara A, Heese K. Possible mechanisms of A beta(1-40)- or A beta(1-42)-induced cell death and their rescue factors. Nippon Yakurigaku Zasshi. 2004; 124: 135-43.
6. Cao Z, Gao Y, Deng K, et al. Receptors for myelin inhibitors: structures and therapeutic opportunities. Mol Cell Neurosci. 43: 4-14.
7. Schnaar RL, Lopez PH. Myelin-associated glycoprotein and its axonal receptors. J Neurosci Res. 2009; 87: 3267-76.
8. Zheng B, Atwal J, Ho C, et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibitionin vitroor promote corticospinal tract regenerationin vivo. Proc Natl Acad Sci USA. 2005; 102: 1205-10.
9. Giger RJ, Venkatesh K, Chivatakarn O, et al. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Restor Neurol Neurosci. 2008; 26: 97-115.
10. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82: 239-59.
11. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41: 479-86.
12. Akatsu H, Takahashi M, Matsukawa N, et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci. 2002; 196: 63-9.
13. Akatsu H, Yamagata H, Chen Y, et al. TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction. Br J Haematol. 2004; 127: 440-7.
14. Heese K, Yamada T, Akatsu H, et al. Characterizing the new transcription regulator protein p60TRP. J Cell Biochem. 2004; 91: 1030-42.
15. Heese K, Otten U, Mathivet P, et al. GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology. 2000; 39: 449-62.
16. Islam O, Gong X, Rose-John S, et al. Interleukin-6 and neural stem cells: more than gliogenesis. Mol Biol Cell. 2009; 20: 188-99.
17. Islam O, Loo TX, Heese K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res. 2009; 6: 42-53.
18. Nehar S, Mishra M, Heese K. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. FEBS Lett. 2009; 583: 3247-53.
19. Shen Y, Inoue N, Heese K. Neurotrophin-4 (Ntf4) mediates neurogenesis in mouse embryonic neural stem cells through the inhibition of the signal transducer and activator of transcription-3 (Stat3) and the modulation of the activity of protein kinase B. Cell Mol Neurobiol. 2010; doi:.
20. Menon KN, Ikeda T, Fujimoto I, et al. Changes in N-linked sugar chain patterns induced by moderate-to-high expression of the galactosyltransferase I gene in a brain-derived cell line, CG4. J Neurosci Res. 2005; 80: 29-36.
21. Gotz R. Regulation of neuronal cell death and differentiation by NGF and IAP family members. J Neural Transm Suppl. 2000: 247-59.
22. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001; 24: 677-736.
23. Deng X, Gao F, Flagg T, et al. Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci USA. 2004; 101: 153-8.
24. Ng YP, Cheung ZH, Ip NY. STAT3 as a downstream mediator of Trk signaling and functions. J Biol Chem. 2006; 281: 15636-44.
25. Gu F, Hata R, Ma YJ, et al. Suppression of Stat3 promotes neurogenesis in cultured neural stem cells. J Neurosci Res. 2005; 81: 163-71.
26. Bang OS, Park EK, Yang SI, et al. Overexpression of Akt inhibits NGF-induced growth arrest and neuronal differentiation of PC12 cells. J Cell Sci. 2001; 114: 81-8.
27. Mori N, Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res. 2002; 70: 264-73.
28. Ng DC, Lin BH, Lim CP, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol. 2006; 172: 245-57.
29. Yoshimura T, Arimura N, Kaibuchi K. Signaling networks in neuronal polarization. J Neurosci. 2006; 26: 10626-30.
30. Yan GZ, Ziff EB. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J Neurosci. 1995; 15: 6200-12.
31. Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for? J Cell Sci. 2003; 116: 3677-85.
32. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, et al. Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene. 2003; 22: 8723-30.
33. Boutin C, Schmitz B, Cremer H, et al. NCAM expression induces neurogenesisin vivo. Eur J Neurosci. 2009; 30: 1209-18.
34. Ebinu JO, Yankner BA. A RIP tide in neuronal signal transduction. Neuron. 2002; 34: 499-502.
35. Ando K, Oishi M, Takeda S, et al. Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J Neurosci. 1999; 19: 4421-7.
36. Kimberly WT, Zheng JB, Town T, et al. Physiological regulation of the beta-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation. J Neurosci. 2005; 25: 5533-43.
37. Zou L, Wang Z, Shen L, et al. Receptor tyrosine kinases positively regulate BACE activity and Amyloid-beta production through enhancing BACE internalization. Cell Res. 2007; 17: 389-401.
38. Lee MS, Kao SC, Lemere CA, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003; 163: 83-95.
39. Vingtdeux V, Hamdane M, Gompel M, et al. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol Dis. 2005; 20: 625-37.
40. He W, Lu Y, Qahwash I, et al. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med. 2004; 10: 959-65.
41. Konishi Y, Stegmuller J, Matsuda T, et al. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science. 2004; 303: 1026-30.
42. Kim AH, Bonni A. Thinking within the D box: initial identification of Cdh1-APC substrates in the nervous system. Mol Cell Neurosci. 2007; 34: 281-7.
43. Huynh MA, Stegmuller J, Litterman N, et al. Regulation of Cdh1-APC function in axon growth by Cdh1 phosphorylation. J Neurosci. 2009; 29: 4322-7.
44. Kim AH, Puram SV, Bilimoria PM, et al. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell. 2009; 136: 322-36.
45. Chivatakarn O, Kaneko S, He Z, et al. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors. J Neurosci. 2007; 27: 7117-24.
46. Teng FY, Ling BM, Tang BL. Inter- and intracellular interactions of Nogo: new findings and hypothesis. J Neurochem. 2004; 89: 801-6.
47. Teng FY, Tang BL. Cell autonomous function of Nogo and reticulons: the emerging story at the endoplasmic reticulum. J Cell Physiol. 2008; 216: 303-8.
48. Atwal JK, Pinkston-Gosse J, Syken J, et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science. 2008; 322: 967-70.